AI tool aims to better assess depression and anxiety

NCT ID NCT07279025

Not yet recruiting Knowledge-focused Sponsor: Deliberate Solutions Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will test a digital tool called AI-COA® to see how well it measures the severity of depression and anxiety compared to standard clinician ratings. About 150 adults in the U.S. who are starting a new treatment for depression or anxiety will use the tool over 12 weeks. The goal is to see if the tool is consistent and sensitive to changes in symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could provide a reliable, automated way to assess depression and anxiety severity, potentially improving monitoring and treatment adjustments.
What could go wrong: This is an early-stage observational study focused on measurement, not treatment. The tool may not prove accurate or practical in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANXIETY DISORDERS DEPRESSION DISORDERS

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Baylor College of Medicine

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.